$BNGO

$1.22 +$0.06 (5.17%) Close

$BNGO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 11.8M shares outstanding

Who owns BNGO?

By type of holder

Institutions 10.2% Insiders 0.1% Everyone else 89.8%

Concentration Top 10 holders own 8.3%

Gsa Capital Partners LLP 1.3% · Cable Car Capital, LP 1.8%

Institutional ownership

10.2%

-0.5 pts vs last qtr

Institutional holders

+2 vs last qtr

Net shares bought

−61.7K

by institutions in Q2 2026

New / sold out

8 / 6

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jane Street Group, LLC NEW +62.2K
Carret Asset Management, LLC +55.0K

Biggest sellers in Q2 2026

Gsa Capital Partners LLP −203.1K
Geode Capital Management, LLC −77.5K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Bionano Genomics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+378.5%

+118.74% a year

Each share's claim on the business

−79.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $29.4M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years13% Under 1 year87%

Quarterly turnover

22.6%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting BNGO on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
GC Gsa Capital Partners LLP	150.3K	1.28%	−203.1K (−57.5%)	Q4 '25	0.0%
Shares held by quarter Peak holding353.4K (Q1'26) Change over 8 quarters+49.9K Share of the company1.280% Gsa Capital Partners LLP's full portfolio →
CC Cable Car Capital, LP	216.8K	1.84%	Unchanged	Q1 '26	0.0%
Shares held by quarter Peak holding216.8K (Q1'26) Change over 8 quarters+216.8K Share of the company1.840% Cable Car Capital, LP's full portfolio →

Gsa Capital Partners LLP

150.3K

% of company

1.28%

Change vs last qtr

−203.1K (−57.5%)

Held since

Q4 '25

Cable Car Capital, LP

216.8K

% of company

1.84%

Change vs last qtr

Unchanged

Held since

Q1 '26

28 more super investors behind a free account

See every manager holding Bionano Genomics, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting BNGO on Form N-PORT; together they hold 1.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$93.1K	82.4K	0.70%	0.00%	June 30, 2026
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$68.5K	56.1K	0.48%	0.00%	August 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$93.1K

% of company

0.70%

% of the fund

0.00%

As of

June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$68.5K

% of company

0.48%

% of the fund

0.00%

As of

August 31, 2026

3 more funds behind a free account

See every fund holding Bionano Genomics, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LA Luderer Albert Insider	8.0K	0.07%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.070% Luderer Albert's insider activity →
HR Holmlin R. Erik Insider	1.7K	0.01%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.010% Holmlin R. Erik's insider activity →

Luderer Albert

Insider

8.0K

% of company

0.07%

Change vs last qtr

—

Held since

—

Holmlin R. Erik

Insider

1.7K

% of company

0.01%

Change vs last qtr

—

Held since

—

5 more holders behind a free account

See every insider and 5%+ holder of Bionano Genomics, Inc..

Comments